Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

HKG:2190 Revenue

In the year 2025, Zylox-Tonbridge Medical Technology had annual revenue of 1.06B CNY with 35.15% growth. Zylox-Tonbridge Medical Technology had revenue of 575.52M in the half year ending December 31, 2025, with 93.37% growth.

• Revenue: 1.06B CNY
• Revenue Growth: +35.15%
• P/S Ratio: 6.87
• Revenue / Employee: 1.14M CNY
• Employees: 925
• Market Cap: 8.08B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.06B	275.01M	35.15%
Dec 31, 2024	782.48M	254.72M	48.27%
Dec 31, 2023	527.75M	193.66M	57.97%
Dec 31, 2022	334.09M	156.18M	87.78%
Dec 31, 2021	177.91M	150.28M	543.89%